Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia ; volume:35 ; number:11 ; day:8 ; month:10 ; year:2018 ; pages:1816-1829 ; date:11.2018
Advances in therapy ; 35, Heft 11 (8.10.2018), 1816-1829, 11.2018
- Creator
-
Cornes, Paul
Gascon, Pere
Chan, Stephen
Hameed, Khalid
Mitchell, Catherine R.
Field, Polly
Latymer, Mark
Arantes, Luiz H.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-018-0798-6
- URN
-
urn:nbn:de:101:1-2018122700210544520112
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cornes, Paul
- Gascon, Pere
- Chan, Stephen
- Hameed, Khalid
- Mitchell, Catherine R.
- Field, Polly
- Latymer, Mark
- Arantes, Luiz H.
- SpringerLink (Online service)
Other Objects (12)
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients (Review)
Long-acting granulocyte colony-stimulating factor in primary prophylaxis of early infection in patients with newly diagnosed multiple myeloma
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor
Semisynthesis of Homogeneous, Active Granulocyte Colony‐Stimulating Factor Glycoforms
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients (Review)
Long-acting granulocyte colony-stimulating factor in primary prophylaxis of early infection in patients with newly diagnosed multiple myeloma
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor
Semisynthesis of Homogeneous, Active Granulocyte Colony‐Stimulating Factor Glycoforms
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients (Review)
Long-acting granulocyte colony-stimulating factor in primary prophylaxis of early infection in patients with newly diagnosed multiple myeloma
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor
Semisynthesis of Homogeneous, Active Granulocyte Colony‐Stimulating Factor Glycoforms